分子对接和机器学习的创新整合用于药物发现:从虚拟查到纳米分子抑制剂
Mutasem Omar Taha1, Safa Daoud2
1Department of Pharmaceutical Sciences, Faculty of Pharmacy, University of Jordan, Amman 11942, Jordan. mutasem@ju.edu.jo.
概括
这项研究整合了分子对接,药模拟和用于药物发现的机器学习. 该方法成功地确定了强大的纳米分子抑制剂用于治疗点,如STAT3和HER2.
科学领域:
- 计算化学和化学信息学
- 药物发现和药物化学
- 机器学习在药理学中的应用.
背景情况:
- 合理的药物发现需要有效的方法来识别新的生物活性化合物.
- 通过集成先进的计算技术,可以增强传统的计算机辅助药物设计 (CADD).
- 机器学习 (ML) 为分析复杂的生物和化学数据提供了强大的工具.
研究的目的:
- 提出一个系统的工作流程,集成分子对接,药模拟和机器学习,以实现合理的药物发现.
- 展示通过ML增强CADD的创新策略.
- 为了证明对关键治疗点的强效抑制剂的发现.
主要方法:
- 分子对接,药模拟和机器学习的系统集成.
- 使用基于对接的数据增强和接体受体接触指纹.
- 采用基因算法引导的特征选择和基于SHAP的模型解释.
主要成果:
- 成功识别了针对多个治疗标的纳米分子抑制剂,包括STAT3,TTK,LSD-1和HER2.
- 证明了有效的脚手架跳跃和新化学型的识别.
- 验证了ML与传统CADD方法的协同组合.
结论:
- 展示的综合工作流显著提高了合理药物发现的效率.
- 机器学习是一个强大的协同工具,用于推进CADD和识别有力的生物活性线索.
- 这种方法有助于发现各种疾病的新疗法.
更多相关视频
10:21Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
Published on: February 23, 2024
3.9K
08:15Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
1.0K
相关概念视频
Drug Discovery: Overview
12.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
12.8K
Ligand Binding Sites
15.7K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
15.7K
Ligand Binding Sites
9.0K
9.0K
Protein-protein Interfaces
15.0K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
15.0K
Protein-Drug Binding: Determination Methods
766
Determining protein-drug binding can be achieved through indirect and direct methods, each providing valuable insights into the interaction between proteins and drugs.
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
766
Protein-Drug Binding: Mechanism and Kinetics
2.0K
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
2.0K
